Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Dyspneic and Non-Dyspneic (Silent) Hypoxemia in Covid-19: Possible Neurological Mechanism Publisher Pubmed



Nourivaskeh M1, 2 ; Sharifi A3 ; Khalili N2, 4 ; Zand R5 ; Sharifi A3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal, Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Neurology, Neuroscience Institute, Geisinger Health System, Danville, PA, United States

Source: Clinical Neurology and Neurosurgery Published:2020


Abstract

SARS-CoV-2 mainly invades respiratory epithelial cells by adhesion to angiotensin-converting enzyme 2 (ACE-2) and thus, infected patients may develop mild to severe inflammatory responses and acute lung injury. Afferent impulses that result from the stimulation of pulmonary mechano-chemoreceptors, peripheral and central chemoreceptors by inflammatory cytokines are conducted to the brainstem. Integration and processing of these input signals occur within the central nervous system, especially in the limbic system and sensorimotor cortex, and importantly feedback regulation exists between O2, CO2, and blood pH. Despite the intensity of hypoxemia in COVID-19, the intensity of dyspnea sensation is inappropriate to the degree of hypoxemia in some patients (silent hypoxemia). We hypothesize that SARS-CoV-2 may cause neuronal damage in the corticolimbic network and subsequently alter the perception of dyspnea and the control of respiration. SARS-CoV-2 neuronal infection may change the secretion of numerous endogenous neuropeptides or neurotransmitters that distribute through large areas of the nervous system to produce cellular and perceptual effects. SARS-CoV-2 mainly enter to CNS via direct (neuronal and hematologic route) and indirect route. We theorize that SARS-CoV-2 infection-induced neuronal cell damage and may change the balance of endogenous neuropeptides or neurotransmitters that distribute through large areas of the nervous system to produce cellular and perceptual effects. Thus, SARS-CoV-2-associated neuronal damage may influence the control of respiration by interacting in neuromodulation. This would open up possible lines of study for the progress in the central mechanism of COVID-19-induced hypoxia. Future research is desirable to confirm or disprove such a hypothesis. © 2020 Elsevier B.V.
Other Related Docs
11. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
12. Covid-19: Neuroimaging Features of a Pandemic, Journal of Neuroimaging (2021)
19. Pathologic Features of Covid-19: A Concise Review, Pathology Research and Practice (2020)
27. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
29. Investigating Neurological Manifestations of Sars-Cov-2, Journal of Neuroimmune Pharmacology (2021)
34. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
39. Histopathologic Changes and Cellular Events of Organs Systems in Covid-19, Journal of Cellular and Molecular Anesthesia (2021)
41. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
42. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
43. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
45. Central Nervous System Involvement in Covid-19, Archives of Medical Research (2020)